At the request of Great Britain, the European Medicines Agency (EMA) has initiated a review procedure in accordance with Article 31 of Directive 2001/83/EC regarding valproate, valproic acid and related substances.

To the risk assessment procedure (available in German only)

Details on the procedure can be found on the website of the European Medicines Agency (EMA):